Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Other Non Operating Income (2023 - 2025)

Historic Other Non Operating Income for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $1.6 million.

  • Compass Therapeutics' Other Non Operating Income fell 1137.66% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 2693.81%. This contributed to the annual value of $7.2 million for FY2024, which is 786.63% down from last year.
  • Latest data reveals that Compass Therapeutics reported Other Non Operating Income of $1.6 million as of Q3 2025, which was down 1137.66% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Compass Therapeutics' Other Non Operating Income ranged from a high of $2.1 million in Q2 2023 and a low of $1.2 million during Q2 2025
  • For the 3-year period, Compass Therapeutics' Other Non Operating Income averaged around $1.7 million, with its median value being $1.9 million (2023).
  • As far as peak fluctuations go, Compass Therapeutics' Other Non Operating Income skyrocketed by 581.64% in 2024, and later tumbled by 3981.72% in 2025.
  • Compass Therapeutics' Other Non Operating Income (Quarter) stood at $2.0 million in 2023, then fell by 22.09% to $1.5 million in 2024, then rose by 1.1% to $1.6 million in 2025.
  • Its Other Non Operating Income stands at $1.6 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.3 million for Q1 2025.